# Elevate Surgical – FDA Inspection, Mar 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/elevate-surgical/72b14923-519a-488a-93f0-01a8c394ed55
Source feed: FDA_Inspections

> FDA inspection 1309442 of Elevate Surgical, March 26, 2026. 3 citations under 21 CFR part 1271. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309442
- Company Name: Elevate Surgical
- Inspection Date: 2026-03-26
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1211565 - 2023-07-27
- FDA Inspection 1064242 - 2018-08-01

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/creighton-t-tuzon/be0d09c0-59f4-48c3-9e3d-a1ceb2587e3e)
- [Issuing Officer](https://www.keypedia.com/people/james-a-banks/6838e911-c630-4a7c-8198-f3936ef6c5f8)

Company: https://www.keypedia.com/companies/elevate-surgical/5a4b8675-fd34-4225-b025-bd9ca7976d35

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
